It has been found that LCN-2 participates in the development of heart failure, myocardial hypertrophy, myocardial ischemia-reperfusion injury, chemotherapy-related cardiac function injury, and other heart diseases (16–18). This evidence concerns the gene LCN2 and myocardial ischemia.